The Effect of Aerobic Exercise on an Elliptical Trainer Versus a Treadmill, in People With Multiple Sclerosis
NCT ID: NCT06583967
Last Updated: 2026-01-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
30 participants
INTERVENTIONAL
2024-06-01
2025-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
High-Intensity, Dynamic-stability Gait Training in People With Multiple Sclerosis
NCT05735691
The Effects of Aerobics Training on Balance in Patients With Multiple Sclerosis
NCT01453868
The Neural Mechanisms of Split-belt Treadmill Adaptation in People With Multiple Sclerosis
NCT05878873
The Effects of Trunk Stabilization and Aerobic Trainings in Multiple Sclerosis
NCT05029700
Changes in Speed, Endurance and Balance in Women Patients With Multiple Sclerosis After 4 & 8 Weeks of Aquatic Exercise Training
NCT02882724
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Outcome measures will be measured by using, 6 min. walking test (6MWT), Timed Up \& Go (TUG), Berg Balance Scale (BBS) and 10 Meter Walk Test (10MWT) to be used to assess the quality of life at Baseline (T0), During study - 6 weeks from baseline (T1), End of training program - 12 weeks from baseline (T2) and 6 weeks post T2 (T3).
The exercise program to be applied for 12 weeks with 2 trainings per week.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group 1 - Elliptical Trainer
15 MS subjects will be enrolled and assigned to group 1 and to be trained (Elliptical Trainer) twice a week for 12 weeks.
Physical Training
Group 1 - Elliptical Trainer Group 2 - Treadmill
Group 2 - Treadmill
15 MS subjects will be enrolled and assigned to group 2 and to be trained (Treadmill) twice a week for 12 weeks.
Physical Training
Group 1 - Elliptical Trainer Group 2 - Treadmill
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Physical Training
Group 1 - Elliptical Trainer Group 2 - Treadmill
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. At least 6 months post MS diagnosis
3. 25-55 years old adults
4. EDSS 3.0-6.5
5. Standing stability - for at least 30 seconds
6. 6MWT - minimal distance to be measured as 210 meters
7. No physical routinely training e.g. walking, elliptical or cycling within 3 months prior screening visit.
Exclusion Criteria
2. Lungs and/or respiratory system diseases
3. Metabolic Disease
4. Any other medical condition(s) which might impact the patient's participant in the study, as per PI medical judgement
5. Major medical treatment change (as per PI medical judgement) up to 12 weeks prior ICF signature by the patient.
25 Years
55 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Soroka University Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Iuly Treger, M.D., PhD, MHA
Principal Investigator, Head of Rehabilitation Department
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Iuly Treger, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Soroka University Medical Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Soroka Medical Center
Beersheba, Israel, Israel
Israel ParaSport Center
Ramat Gan, Israel, Israel
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
0104-23-SOR
Identifier Type: OTHER
Identifier Source: secondary_id
0104-23-SOR
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.